Sheffield Deborah L. 4
4 · Northstar Neuroscience, Inc. · Filed Mar 13, 2009
Insider Transaction Report
Form 4
Sheffield Deborah L.
VP, Clinical & Regulatory
Transactions
- Exercise/Conversion
Common Stock
2009-03-11$1.72/sh+52,500$90,300→ 64,163 total - Exercise/Conversion
Stock Option (right to buy)
2009-03-11−48,496→ 4,004 totalExercise: $1.72From: 2009-01-31Exp: 2018-03-31→ Common Stock (48,496 underlying) - Exercise/Conversion
Stock Option (right to buy)
2009-03-11−4,004→ 0 totalExercise: $1.72From: 2009-01-31Exp: 2018-03-31→ Common Stock (4,004 underlying) - Exercise/Conversion
Common Stock
2009-03-11$1.56/sh+25,500$39,780→ 89,663 total - Tax Payment
Common Stock
2009-03-11$1.95/sh−68,527$133,628→ 21,136 total - Exercise/Conversion
Stock Option (right to buy)
2009-03-11−25,500→ 0 totalExercise: $1.56From: 2009-01-31Exp: 2018-09-14→ Common Stock (25,500 underlying)
Holdings
- 10,516
Common Stock
Footnotes (1)
- [F1]Reflects shares of common stock settled net directly with the Company and withheld by the Company for payment of exercise price and to satisfy tax obligations upon exercise.